Fit the patient morphology with the appropriated probe
The mobile non-invasive solution for liver disease management, ideal for multi-site configuration
Powered by LSM by VCTE™ and CAP™ for liver disease management.
FibroScan® Mini+ 430 is designed for multi-center sharing and remote liver patient management.
LSM by VCTE™ is unique, patented and validated for Liver Stiffness Measurement1. 2,750 peer-reviewed publications support the use of LSM by VCTE™.
CAPTM is unique patented and validated for liver disease management. 605 international peer-reviewed publications support the use of CAP™.
Assessment of liver stiffness and fat by non-invasive method is a huge step forward towards better management of NAFLD. It has hugely impacted the way clinicians stratify the patients, chose therapy and monitor response!
FibroScan® 430 Mini+ Indications for Use
The FibroScan® 430 Mini+ is intended to provide 50Hz shear wave speed measurements and estimates of tissue stiffness as well as 3.5 MHz ultrasound coefficient of attenuation (CAP: Controlled Attenuation Parameter) in internal structures of the body. The FibroScan® 430 Mini+ is indicated for non-invasive measurement in the liver of 50 Hz shear wave speed and estimates of stiffness as well as determining a 3.5 MHz ultrasound coefficient for the Attenuation Parameter (CAP: Controlled Attenuation Parameter). The shear wave speed and stiffness, and CAP may be used as an aid to diagnosis and monitoring of adult patients with liver disease, as part of an overall assessment of the liver. Shear wave speed and stiffness may be used as an aid in the clinical management of pediatric patients with liver disease.
References are available in our bibliography.